Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,176 | -3,283 | -2,124 | -1,073 | -4,679 |
| Depreciation Amortization | 7 | N/A | N/A | N/A | 2 |
| Accounts receivable | 2 | 5 | 3 | 3 | -4 |
| Accounts payable and accrued liabilities | 97 | 327 | 293 | 315 | -100 |
| Other Working Capital | 473 | 382 | 368 | 233 | -729 |
| Other Operating Activity | 728 | 252 | -13 | -250 | 539 |
| Operating Cash Flow | $-2,869 | $-2,317 | $-1,473 | $-772 | $-4,971 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -98 | -97 | N/A | N/A | N/A |
| Investing Cash Flow | $-98 | $-97 | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,911 | 1,911 | 1,911 | N/A | N/A |
| Other Financing Activity | 1,350 | 1,350 | 1,350 | 0 | 0 |
| Financing Cash Flow | $3,261 | $3,261 | $3,261 | $0 | $N/A |
| Beginning Cash Position | 1,091 | 1,091 | 1,091 | 1,091 | 6,062 |
| End Cash Position | 1,385 | 1,938 | 2,879 | 319 | 1,091 |
| Net Cash Flow | $294 | $847 | $1,788 | $-772 | $-4,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,869 | -2,317 | -1,473 | -772 | -4,971 |
| Capital Expenditure | -98 | -97 | N/A | N/A | N/A |
| Free Cash Flow | -2,967 | -2,414 | -1,473 | -772 | -4,971 |